Developing an adherence questionnaire (C-MABQ) for bipolar disorder

  • Research type

    Research Study

  • Full title

    Developing a questionnaire (C-MABQ) to identify what helps and hinders medication adherence in bipolar disorder

  • IRAS ID

    261687

  • Contact name

    Asta Ratna Prajapati

  • Contact email

    asta.prajapati@nhs.net

  • Sponsor organisation

    Norfolk and Suffolk NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 5 months, 27 days

  • Research summary

    This is the 2nd stage of overall research project to develop and test medication adherence questionnaire for bipolar disorder. The first stage was systematic review.
    In this study, we plan to undertake a qualitative work to develop a “Collaborative Medication Adherence in Bipolar disorder Questionnaire (C-MABQ)” to identify what helps and hinders patients in taking their medication as prescribed [adherence]. We are calling those helps and hindrances adherence ‘Determinants’. This qualitative study includes three steps:

    1. Focus groups and interviews with patients with bipolar disorder and their carers

    We have completed a systematic review of the modifiable determinants of medication adherence to establish what is already known. We will formulate these determinants into brief statements intended to be understood by lay person to encourage full participation by participants in the focus groups/interviews. The findings from focus groups/interviews will help us refine and prioritize the determinants and statement about the determinants of adherence from the perspective of patients and carers and explore any gaps in the literature.

    2. Consultation with healthcare professionals and experts in behaviour change

    We will present these refined statements to healthcare practitioners and experts in behaviour change for their feedback. Based on the feedback, we will make any further required refinements to these statements to generate the first full draft of the C-MABQ.

    3. Cognitive interviews with patients with bipolar disorder

    We will then conduct cognitive interviews with patients to identify any difficulties in understanding of and responding to the C-MABQ statements. This will enable us to check if any wording needs to be changed, statements need to be reorganised or presentation features need altering e.g. font type and size. Based on the cognitive interview findings, we will make any final necessary refinements to produce final C-MABQ.

  • REC name

    East of England - Cambridgeshire and Hertfordshire Research Ethics Committee

  • REC reference

    19/EE/0288

  • Date of REC Opinion

    20 Dec 2019

  • REC opinion

    Further Information Favourable Opinion